New research to be presented at #ASCO25 highlights role of microRNA-based genetic ... efficacy with long-term quality of life." Poster Presentation #21 (Abstract #11538): Personalized Radiation ...

LONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced the Company will exhibit ...

today announced the Company will exhibit four poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting, which is being held from May 13-17, 2025 ...

In the rapidly evolving landscape of healthcare and pharmaceutical market access, data analytics has become a critical ...

The poster is scheduled for presentation on May 31, 2025 ... Telomeres, along with the enzyme telomerase, play a fundamental role in the survival of cancer cells and their resistance to current ...

The 2025-26 Budget will see a $5 million investment to further expand the role of pharmacists ... pilot to allow pharmacists to prescribe medications in aged care settings. “Better medication ...

According to Future Market Insights, myelofibrosis (mf) treatment market is expected to grow at a CAGR of 5.5% between 2023 and 2033, reaching USD 1,280 Million by 2033. The market is expected to ...

From saving lives by encouraging people to come forward with cancer concerns or helping people to access support with their mental health, through to encouraging uptake of NHS screening programmes, ...

The advent of novel cancer care therapies such as chimeric antigen receptor T-cell therapy and bispecific antibodies is transforming the role of pharmacists in enhancing patient care. The role of ...

Pharmacists enhance value-based care by selecting cost-effective treatments, managing adherence, and preventing hospitalizations through collaborative multidisciplinary teamwork, said Eileen Peng, ...